PROPESS Izrael - angličtina - Ministry of Health

propess

ferring pharmaceuticals ltd - dinoprostone - pessary - dinoprostone 10 mg - dinoprostone - dinoprostone - initiation and/or continuation of cervical ripening in patients at term, from 38th week of gestation, with bishop score of 6 or less.

Chair, rotating, vestibulo-ocular function Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

chair, rotating, vestibulo-ocular function

interacoustics pty ltd - 17217 - chair, rotating, vestibulo-ocular function - a dedicated chair used in the assessment of vestibulo-ocular reflex during head movement through the evaluation of rhythmic movement (nystagmus) and / or deviation of the eyes in response to the stimulation of the vestibular system by angular acceleration or deceleration. this device is motor-driven which provides the precisely controlled rotation (direction, velocity, acceleration) of the chair

Lift, patient transfer, <specify> Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

lift, patient transfer, <specify>

nl-tec pty ltd - 31169 - lift, patient transfer, - intended purpose of use of the device the zephyr patient transfer system is used to aid in the support, positioning, and movement of a patient during radiological or other procedures.

Patient positioning device, diagnostic imaging/radiotherapy, whole body Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

patient positioning device, diagnostic imaging/radiotherapy, whole body

ge healthcare australia pty ltd - 40902 - patient positioning device, diagnostic imaging/radiotherapy, whole body - this device comprising of fixed or adjustable position elements is intended to ensure adequate positioning and/or immobilization of the patient's whole body during diagnostic imaging, image guided surgical or interventional procedures and/or radiation therapy procedures.

DURATOCIN INJECTION 100 mcgml Singapur - angličtina - HSA (Health Sciences Authority)

duratocin injection 100 mcgml

ferring pharmaceuticals private limited - carbetocin - injection - 100 mcg - carbetocin 100 mcg/ml

CHIROCAINE INJECTION 2.5 mgml Singapur - angličtina - HSA (Health Sciences Authority)

chirocaine injection 2.5 mgml

abbvie pte. ltd. - levobupivacaine hcl - injection - 2.5 mg/ml - levobupivacaine hcl 2.5 mg/ml

CHIROCAINE INJECTION 5 mgml Singapur - angličtina - HSA (Health Sciences Authority)

chirocaine injection 5 mgml

abbvie pte. ltd. - levobupivacaine hcl - injection - 5 mg/ml - levobupivacaine hcl 5 mg/ml

CHIROCAINE INJECTION 7.5 mgml Singapur - angličtina - HSA (Health Sciences Authority)

chirocaine injection 7.5 mgml

abbvie pte. ltd. - levobupivacaine hcl - injection - 7.5 mg/ml - levobupivacaine hcl 7.5 mg/ml

Ophthalmic tonometer probe, sterile Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

ophthalmic tonometer probe, sterile

designs for vision aust pty ltd - 62405 - ophthalmic tonometer probe, sterile - a sterile single use device intended to be attached to an ophthalmic tonometer and to make brief and gentle contact with the eye surface for the measurement of intraocular pressure (iop). it is a thin metal rod with a plastic distal tip designed to be moved towards the eye by the tonometer via magnetization. probe deceleration and rebound time measurements are used to calculate iop.

Neonatal/paediatric heart rate monitoring application software Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

neonatal/paediatric heart rate monitoring application software

device technologies australia pty ltd - 58703 - neonatal/paediatric heart rate monitoring application software - hero is intended to acquire, store, analyze, and report on ecg data collected from infants. hero is intended to be used by trained operators under the direct supervision of a licensed health care practitioner in a hospital neonatal or pediatric icu environment. hero is intended to be used for the analysis of the variability in rr intervals (heart rate) and to report measurements of the variability of heart rate data (hrv). the hrv measurements reported by hero are specialized in nature, and intended to identify periods of transient decelerations and/or reduced baseline variability in the heart rate. hero is intended to provide specialized hrv measurements and may detect arrhythmias, that when combined with other risk factors, can be used as an aid in assessing the risk of sepsis in infants. the use of the hero monitoring improves survival in very low birth weight neonates.